Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Horizon Provides Assurances That Tepezza Sales Are Set To Soar
Guidance Maintained For 30% Growth In 2022
May 05 2022
•
By
Mandy Jackson
Horizon expects more than 30% Tepezza sales growth in 2022 • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip